Image For Activity Cover
Advanced Course in Diabetes Complications
This course is a result of the collaboration Between ADA and Mankind Pharma to benefit millions of people living with diabetes in India. This collaboration is aimed at a mission to prevent diabetes and improve the lives of all people affected by diabetes in India through health care professional education.
Overview

This course is a result of the collaboration Between ADA and Mankind Pharma to benefit millions of people living with diabetes in India. This collaboration is aimed at a mission to prevent diabetes and improve the lives of all people affected by diabetes in India through health care professional education.

Diabetes is a major cause of heart attacks, stroke, kidney failure and lower limb amputation around the world. Primary health care professionals stand on the frontline of care delivery for the 422+ million individuals living with diabetes around the world with over 77 million people with diabetes living in India.

The course "Advanced course in Diabetes Complications" is composed of three modules. Each module has a short video from an expert to discuss their perspective in terms of the condition in India.

Learning Objectives
Module 1: Diabetes Complications
  • Recognize risk factors, pathophysiology, and advances in early detection and treatment of diabetes-related complications, such as vision loss and neuropathy.
  • Examine the role of screening for diabetes-related complications in asymptomatic people with diabetes.
  • Recall the role of new agents in mitigating risk of complications.
  • Recall the importance of regular exams and screening for complications.

Module 2: Screening, Prevention and Management of Chronic Kidney Disease
  • Identify the pathophysiology and risk factors of chronic kidney disease in diabetes.  
  • Recall screening and monitoring best practices for chronic kidney disease in diabetes.  
  • Recognize lifestyle modifications and pharmacological treatment of chronic kidney disease in diabetes.  
  • Compare new therapies with cardiovascular and kidney effects. 

Module 3: Screening, Prevention and Management of Cardiovascular Disease
  • Identify the burden of cardiovascular disease in diabetes.  
  • Recognize cardiovascular risk factors and pathophysiology of cardiovascular complications.  
  • Select antihypertensive, lipid-lowering, and antiplatelet therapy.  
  • Examine the role of screening for coronary artery disease in asymptomatic patients with diabetes.  
  • Recall the role of new agents, SGLT2 inhibitors and GLP-1 RA, in mitigating cardiorenal risk.
Faculty

Dr. Sanjay Kalra, MD, DM
Consultant, Department of Endocrinology
Bharti Hospital, Karnal, India

Sanjay Kalra is an endocrinologist practicing at Karnal, India. Chairperson of the Education Working Group, and Executive Committee member, International Society of Endocrinology, (ISE) he works to enhance global cooperation in endocrine research and obesity. Having served in the past as the President, South Asian Federation of Endocrine Societies(SAFES), Endocrine Society of India (ESI), as well as Indian Professional Association for Transgender Health (IPATH), he has strengthened endocrine care in the region and beyond.

With a focus on person-centered diabetes and obesity management, Sanjay continues to facilitate improve advocacy clinical care, education and research in his field. These efforts include encouragement of cross-disciplinary and transnational collaboration. The 1000+ papers of his on PubMed bear testimony to his hard work.

Apart from this, Sanjay enjoys dancing the Punjabi folk dance bhangra, and exercising with the traditional Haryanvi bell club, the mudgar. He is currently engaged in trying to create a new hybrid dance form, aerokabaddi.


Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
Professor of Medicine
Emory University School of Medicine

Dr. Umpierrez is professor of medicine in the division of endocrinology at Emory University School of Medicine, Director of the Grady Memorial Hospital Clinical Research Network, Atlanta-CTSA, and Director of the diabetes and endocrinology section at Grady Memorial Hospital.

Dr. Umpierrez first joined the Emory University School of Medicine faculty in 1992. He is the recipient of numerous teaching awards for Best Clinical Teacher and Best Mentor of Endocrine Fellows and Junior Faculty at Emory University, J. Willis Hurst Outstanding Bedside Teacher Award, American College of Physicians, Outstanding Service Award for the Promotion of Endocrine Health of an Underserved Population, American Association of Clinical Endocrinologists' (AACE), the American Diabetes Association, 2013 Outstanding Physician Clinician in Diabetes Award, and the 2013-2014 Best Grand Rounds Lecture Award, Department of Medicine at Emory University. He is a member of the National Board of Directors for the American Diabetes Association and the American Association Clinical Endocrinologists, as well as a member of the Endocrine Society Clinical Guideline Committee and American Association Clinical Endocrinologists Diabetes Scientific Council.

His research interests include mechanisms for Beta-cell dysfunction in minority populations and the management of inpatient hyperglycemia. He is a national and international leader in the field of hospital management of diabetes and has published several landmark papers and guidelines in the field of inpatient diabetes. His research program is currently funded by the National Institutes of Health and American Diabetes Association, and by investigator-initiated research trials aiming to determine best insulin protocols for the management of hospitalized patients with diabetes. He heads the Emory Latino Diabetes Education Program, a nationally accredited Spanish Diabetes education program dedicated to providing diabetes education to Latinos.

Dr. Umpierrez is the Editor-in-Chief of the American Diabetes Association Therapy for Diabetes Mellitus and Related Disorders, 6th Edition Textbook (Green Book), and the Editor-in-Chief of the BMJ Open Diabetes Research & Care (ADA and BMJ Collaborative project). He has published more than 200 scientific manuscripts and book chapters, and has presented over 180 research abstracts at national and international scientific meetings.

Summary
Availability: On-Demand
Expires on 08/20/2026
Cost: FREE
Credit Offered:
No Credit Offered
Contains: 3 Courses
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright All rights reserved.
Android App Download IOS App Download Powered By